The Cost-effectiveness Analysis of Chuanhuning and Ribavirin in Treatment of Viral Pneumonia / 中国药房
China Pharmacy
;
(12)1991.
Artículo
en Chino
| WPRIM
| ID: wpr-520863
ABSTRACT
OBJECTIVE:
To compare the therapeutic effect and cost-effectiveness ratio between chuanhuning and rib?avirin in treatment of viral pneumonia.METHODS:
63patients with viral pneumonia were divided into chuanhuning and rib?avirin groups and pharmacoeconomic cost-effectiveness analysis was carried out.RESULTS&CONCLUSION:
In treating viral pneumonia,there is a great disparity in price between chuanhuning and ribavirin,however,the costs of two groups were very close,and so were the cost-effectiveness ratios.Chuanhuning is better than ribavirin in paying.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Evaluación Económica en Salud
Idioma:
Chino
Revista:
China Pharmacy
Año:
1991
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS